Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP2D6 ultra-rapid metabolizer phenotype not associated with attempted suicide in a large sample of psychiatric inpatients.

Pharmacogenomics - 1 Aug 2016

Stephens Dustin B, de Leon Jose

Abstract excerpt

AIM: Suicide accounts for over 800,000 deaths per year worldwide and is the tenth-leading cause of mortality in USA. Several studies have investigated cytochrome P450 CYP2D6 ultra-rapid metabolizer (UM) phenotype in relation to suicidality, with mixed results. This study tested the hypothesis of increased suicide risk among CYP2D6 UMs. PATIENTS & METHODS: Among the 4264 state psychiatric hospital inpatients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cytochrome P-450 CYP2D6
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inpatients

Share to Mental Disorders

Share to Risk Assessment

Share to Socioeconomic Factors

Share to Suicide, Attempted

Source

Identifiers

PMID: 27463022
DOI: 10.2217/pgs-2016-0086

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP2D6 ultra-rapid metabolizer phenotype not associated with attempted suicide in a large sample of psychiatric inpatients.PMID 27463022Read ↗

CYP2D6 polymorphism and mental and personality disorders in suicide attempters.Semantic proximity Read ↗

A combined high CYP2D6-CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstances.Semantic proximity Read ↗

A one-year follow-up study of treatment-compliant suicide attempt survivors: relationship of CYP2D6-CYP2C19 and polypharmacy with suicide reattempts.Semantic proximity Read ↗

Completed suicides of citalopram users-the role of CYP genotypes and adverse drug interactions.Semantic proximity Read ↗

Polymorphism rs754203 in Gene CYP46A1 Is a Potential Suicide Risk Biomarker in Major Depressive DisorderSemantic proximity Read ↗

The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder.Semantic proximity Read ↗

Non-response to consecutive antidepressant therapy caused by CYP2D6 ultrarapid metabolizer phenotype.Semantic proximity Read ↗

Prevalence of patients using drugs metabolized by cytochrome P450 2D6 in different populations: a cross-sectional study.Semantic proximity Read ↗

The Relationship Between CYP46A1 Polymorphism and Suicide Risk: A Preliminary Investigation.Semantic proximity Read ↗

Effects of vitamin D-related gene polymorphisms on attempted suicide.Semantic proximity Read ↗

Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.Semantic proximity Read ↗

Risk Phenotypes, Comorbidities, Pharmacotherapy, and Electroconvulsive Therapy (ECT) in a Cohort with Difficult-to-Treat Depression in Comparison to an Unmedicated Control Group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.